Award
National Cancer Institute 11232609
Modulation of intracellular lipid access by ATGL determines ferroptosis sensitivity in castration-resistant prostate cancer
Recipient
University of Texas MD Anderson Cancer Center
Award Amount
$39,203.00
Ceiling
$39,203.00
Awarded
July 29, 2025
Identifier
11232609
Research project investigating how ATGL affects ferroptosis sensitivity in castration-resistant prostate cancer, including therapeutic strategy evaluation.
Description
This project aims to investigate the role of adipose triglyceride lipase (ATGL) in mediating ferroptosis resistance in castration-resistant prostate cancer (CRPC). The research will explore the mechanisms by which ATGL influences lipid metabolism and ferroptosis pathways, and evaluate combined therapeutic strategies involving ATGL inhibitors, ferroptosis inducers, and anti-androgens.